Baker Bros. Advisors LP 13D and 13G filings for Candel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 4:33 pm Sale |
2025-03-31 | 13G | Candel Therapeutics, Inc. CADL |
Baker Bros. Advisors LP | 2,455,108 4.990% |
-526,875 (-17.67%) |
Filing |
| 2025-02-14 4:14 pm Purchase |
2024-12-31 | 13G | Candel Therapeutics, Inc. CADL |
Baker Bros. Advisors LP | 2,981,983 6.800% |
2,981,983 (New Position) |
Filing |